Amicus Therapeutics CEO sells $75,523 in stock, buys options By Investing.com
Amicus (NASDAQ:) Therapeutics, Inc. (NASDAQ:FOLD) President and CEO Bradley L. Campbell recently engaged in transactions involving the company's common stock, according to a new filing with the Securities and Exchange Commission. On…